These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16877784)

  • 1. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale.
    Alaeddini J; Feghali G; Jenkins S; Ramee S; White C; Abi-Samra F
    J Invasive Cardiol; 2006 Aug; 18(8):365-8. PubMed ID: 16877784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic tachy- and bradyarrhythmias after transcatheter closure of interatrial communications with Amplatzer devices.
    Szkutnik M; Lenarczyk A; Kusa J; Białkowski J
    Cardiol J; 2008; 15(6):510-6. PubMed ID: 19039754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients.
    Krumsdorf U; Ostermayer S; Billinger K; Trepels T; Zadan E; Horvath K; Sievert H
    J Am Coll Cardiol; 2004 Jan; 43(2):302-9. PubMed ID: 14736453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of balloon pull-through technique to assist in CardioSEAL device closure of patent foramen ovale.
    Chintala K; Turner DR; Leaman S; Rodriguez-Cruz E; Wynne J; Greenbaum A; Forbes TJ
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):101-6. PubMed ID: 12929112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
    Earing MG; Cabalka AK; Seward JB; Bruce CJ; Reeder GS; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):24-34. PubMed ID: 14708945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
    Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
    Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients].
    La Rosée K; Krause D; Becker M; Beuckelmann DJ; Deutsch HJ; Höpp HW
    Dtsch Med Wochenschr; 2001 Sep; 126(38):1030-6. PubMed ID: 11565056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices.
    Krumsdorf U; Keppeler P; Horvath K; Zadan E; Schrader R; Sievert H
    J Interv Cardiol; 2001 Feb; 14(1):49-55. PubMed ID: 12053327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year experience with percutaneous closure of patent foramen ovale.
    Slavin L; Tobis JM; Rangarajan K; Dao C; Krivokapich J; Liebeskind DS
    Am J Cardiol; 2007 May; 99(9):1316-20. PubMed ID: 17478165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler.
    Anzola GP; Morandi E; Casilli F; Onorato E
    Stroke; 2004 Sep; 35(9):2140-4. PubMed ID: 15284445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
    Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter patent foramen ovale closure using the Premere PFO occlusion system.
    Donti A; Giardini A; Salomone L; Formigari R; Picchio FM
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):736-40. PubMed ID: 17039524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
    J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter device closure of interatrial septal defects in patients with hypoxia.
    Ilkhanoff L; Naidu SS; Rohatgi S; Ross MJ; Silvestry FE; Herrmann HC
    J Interv Cardiol; 2005 Aug; 18(4):227-32. PubMed ID: 16115150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.